Europe Contrast Media Agent and Injector System Market: Analysis and Forecast: 2022-2026
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 1-5 working days.
Introduction to Europe Contrast Media Agent and Injector System Market
The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026. The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.
Market Introduction
The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies. Contrast media agents and injector systems play a crucial role in enhancing the visibility of anatomical structures during imaging procedures such as CT scans, MRI scans, and angiography. With a growing aging population and rising healthcare expenditures, there is a heightened emphasis on early disease detection and accurate diagnosis, further fueling the demand for contrast media agents and injector systems in Europe. Additionally, ongoing research and development activities aimed at improving imaging techniques and patient outcomes are expected to drive market growth. Regulatory initiatives aimed at ensuring patient safety and the availability of innovative imaging solutions also contribute to market expansion in the region.
Market Segmentation:
Segmentation 1: by Product
Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Some of the prominent names established in this market are:
This report will be delivered in 1-5 working days.
Introduction to Europe Contrast Media Agent and Injector System Market
The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026. The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.
Market Introduction
The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies. Contrast media agents and injector systems play a crucial role in enhancing the visibility of anatomical structures during imaging procedures such as CT scans, MRI scans, and angiography. With a growing aging population and rising healthcare expenditures, there is a heightened emphasis on early disease detection and accurate diagnosis, further fueling the demand for contrast media agents and injector systems in Europe. Additionally, ongoing research and development activities aimed at improving imaging techniques and patient outcomes are expected to drive market growth. Regulatory initiatives aimed at ensuring patient safety and the availability of innovative imaging solutions also contribute to market expansion in the region.
Market Segmentation:
Segmentation 1: by Product
- Contrast Media Agents
- Injector Systems
- Injector
- Consumables and Accessories
- Germany
- U.K.
- France
- Italy
- Spain
- Rest-of-Europe
Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Some of the prominent names established in this market are:
- Bayer AG
- Bracco Group
- Guerbet
- ulrich GmbH & Co. KG
Executive Summary
Scope of the Study
Research Methodology
1 MARKETS
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Market Overview
1.3 Industry Outlook
1.3.1 Regulatory and Legal Requirements and Framework
1.3.1.1 Regulatory and Legal Requirements and Framework in Europe
1.3.2 Patent Analysis
1.3.2.1 Patent Filing Trend (by Year)
1.3.2.2 Patent Filing Trend (by Country)
1.3.3 Key Trends
1.3.3.1 Nanoparticle-Based Contrast Agents
1.3.3.2 Development of Safer Contrast Media Agent
1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
1.4.1 Pre-COVID-19 Impact
1.4.2 During COVID-19 Impact
1.4.3 Post-COVID-19 Impact
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
1.5.2.3 Growing Number of Regulatory Approvals
1.5.3 Market Restraints
1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
1.5.4 Market Opportunities
1.5.4.1 IT Advances in Contrast Media Injectors
2 REGION
2.1 Overview
2.2 Europe
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.2.1 Impact Analysis
2.2.3 Market Size and Forecast
2.2.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
2.2.3.1.1 Europe Contrast Media Injector System Market (by Product)
2.2.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
2.2.3.2.1 Germany
2.2.3.2.1.1 Market Sizing and Forecast
2.2.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
2.2.3.2.2 Italy
2.2.3.2.2.1 Market Sizing and Forecast
2.2.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
2.2.3.2.3 France
2.2.3.2.3.1 Market Sizing and Forecast
2.2.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
2.2.3.2.4 U.K.
2.2.3.2.4.1 Market Sizing and Forecast
2.2.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
2.2.3.2.5 Spain
2.2.3.2.5.1 Market Sizing and Forecast
2.2.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
2.2.3.2.6 Rest-of-Europe
2.2.3.2.6.1 Market Sizing and Forecast
2.2.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Benchmarking
3.1.1 Key Strategies and Development
3.1.1.1 Regulatory and Legal Activities
3.1.1.2 Partnerships, Collaborations, and Business Expansions
3.1.1.3 Mergers and Acquisitions
3.1.1.4 New Offerings
3.1.2 Market Share Analysis
3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
3.2 Contrast Media Ecosystem Active Players
3.3 Company Profiles
3.3.1 Bayer AG
3.3.1.1 Company Overview
3.3.1.2 Role of Bayer AG in the Contrast Media Agent and Injector System Market
3.3.1.3 Financials
3.3.1.4 Recent Developments
3.3.1.5 Analyst Perception
3.3.2 Bracco Group
3.3.2.1 Company Overview
3.3.2.2 Role of Bracco Group in the Contrast Media Agent and Injector System Market
3.3.2.3 Recent Developments
3.3.2.4 Analyst Perception
3.3.3 Fresenius SE & Co. KGaA
3.3.3.1 Company Overview
3.3.3.2 Role of Fresenius SE & Co. KGaA in the Contrast Media Agent and Injector System Market
3.3.3.3 Financials
3.3.3.4 Recent Developments
3.3.3.5 Analyst Perception
3.3.4 Guerbet
3.3.4.1 Company Overview
3.3.4.2 Role of Guerbet in the Contrast Media Agent and Injector System Market
3.3.4.3 Financials
3.3.4.4 Recent Developments
3.3.4.5 Analyst Perception
3.3.5 ulrich GmbH & Co. KG
3.3.5.1 Company Overview
3.3.5.2 Role of ulrich GmbH & Co. KG in the Contrast Media Agent and Injector System Market
3.3.5.3 Recent Developments
3.3.5.4 Analyst Perception
Scope of the Study
Research Methodology
1 MARKETS
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Market Overview
1.3 Industry Outlook
1.3.1 Regulatory and Legal Requirements and Framework
1.3.1.1 Regulatory and Legal Requirements and Framework in Europe
1.3.2 Patent Analysis
1.3.2.1 Patent Filing Trend (by Year)
1.3.2.2 Patent Filing Trend (by Country)
1.3.3 Key Trends
1.3.3.1 Nanoparticle-Based Contrast Agents
1.3.3.2 Development of Safer Contrast Media Agent
1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
1.4.1 Pre-COVID-19 Impact
1.4.2 During COVID-19 Impact
1.4.3 Post-COVID-19 Impact
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
1.5.2.3 Growing Number of Regulatory Approvals
1.5.3 Market Restraints
1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
1.5.4 Market Opportunities
1.5.4.1 IT Advances in Contrast Media Injectors
2 REGION
2.1 Overview
2.2 Europe
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.2.1 Impact Analysis
2.2.3 Market Size and Forecast
2.2.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
2.2.3.1.1 Europe Contrast Media Injector System Market (by Product)
2.2.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
2.2.3.2.1 Germany
2.2.3.2.1.1 Market Sizing and Forecast
2.2.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
2.2.3.2.2 Italy
2.2.3.2.2.1 Market Sizing and Forecast
2.2.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
2.2.3.2.3 France
2.2.3.2.3.1 Market Sizing and Forecast
2.2.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
2.2.3.2.4 U.K.
2.2.3.2.4.1 Market Sizing and Forecast
2.2.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
2.2.3.2.5 Spain
2.2.3.2.5.1 Market Sizing and Forecast
2.2.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
2.2.3.2.6 Rest-of-Europe
2.2.3.2.6.1 Market Sizing and Forecast
2.2.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Benchmarking
3.1.1 Key Strategies and Development
3.1.1.1 Regulatory and Legal Activities
3.1.1.2 Partnerships, Collaborations, and Business Expansions
3.1.1.3 Mergers and Acquisitions
3.1.1.4 New Offerings
3.1.2 Market Share Analysis
3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
3.2 Contrast Media Ecosystem Active Players
3.3 Company Profiles
3.3.1 Bayer AG
3.3.1.1 Company Overview
3.3.1.2 Role of Bayer AG in the Contrast Media Agent and Injector System Market
3.3.1.3 Financials
3.3.1.4 Recent Developments
3.3.1.5 Analyst Perception
3.3.2 Bracco Group
3.3.2.1 Company Overview
3.3.2.2 Role of Bracco Group in the Contrast Media Agent and Injector System Market
3.3.2.3 Recent Developments
3.3.2.4 Analyst Perception
3.3.3 Fresenius SE & Co. KGaA
3.3.3.1 Company Overview
3.3.3.2 Role of Fresenius SE & Co. KGaA in the Contrast Media Agent and Injector System Market
3.3.3.3 Financials
3.3.3.4 Recent Developments
3.3.3.5 Analyst Perception
3.3.4 Guerbet
3.3.4.1 Company Overview
3.3.4.2 Role of Guerbet in the Contrast Media Agent and Injector System Market
3.3.4.3 Financials
3.3.4.4 Recent Developments
3.3.4.5 Analyst Perception
3.3.5 ulrich GmbH & Co. KG
3.3.5.1 Company Overview
3.3.5.2 Role of ulrich GmbH & Co. KG in the Contrast Media Agent and Injector System Market
3.3.5.3 Recent Developments
3.3.5.4 Analyst Perception
LIST OF FIGURES
Figure 1: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 3: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
Figure 4: Contrast Media Agent and Injector System Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
Figure 10: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
Figure 11: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
Figure 12: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
Figure 13: Number of CT Scans Per One Million Inhabitants, 2018-2020
Figure 14: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
Figure 15: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 16: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
Figure 17: Incidence of Cardiovascular Disease, 2015 – 2019, Million
Figure 18: Innovative Vendors Product Solutions
Figure 19: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
Figure 20: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 21: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 22: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 23: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 24: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 25: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 26: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 27: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 28: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 29: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 30: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 31: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 32: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 33: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
Figure 34: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 35: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 36: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 37: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
Figure 38: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 39: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 40: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
Figure 41: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
Figure 42: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 43: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 44: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
Figure 45: Regulatory and Legal Activities, January 2018-May 2023
Figure 46: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
Figure 47: Mergers and Acquisitions, January 2018-May 2023
Figure 48: New Offerings, January 2018-May 2023
Figure 49: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
Figure 50: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
Figure 51: Bayer AG: Product Portfolio
Figure 52: Bayer AG: Overall Financials, $Million, 2020-2022
Figure 53: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
Figure 54: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
Figure 55: Bayer AG: R&D Expenditure, $Million, 2020-2022
Figure 56: Bracco Group: Product Portfolio
Figure 57: Fresenius SE & Co. KGaA: Product Portfolio
Figure 58: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
Figure 59: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
Figure 60: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
Figure 61: Guerbet: Product Portfolio
Figure 62: Guerbet: Overall Financials, $Million, 2020-2022
Figure 63: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
Figure 64: ulrich GmbH & Co. KG: Product Portfolio
Figure 1: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 3: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
Figure 4: Contrast Media Agent and Injector System Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
Figure 10: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
Figure 11: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
Figure 12: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
Figure 13: Number of CT Scans Per One Million Inhabitants, 2018-2020
Figure 14: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
Figure 15: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 16: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
Figure 17: Incidence of Cardiovascular Disease, 2015 – 2019, Million
Figure 18: Innovative Vendors Product Solutions
Figure 19: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
Figure 20: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 21: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 22: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 23: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 24: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 25: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 26: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 27: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 28: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 29: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 30: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 31: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 32: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 33: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
Figure 34: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 35: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 36: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 37: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
Figure 38: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 39: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 40: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
Figure 41: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
Figure 42: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 43: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 44: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
Figure 45: Regulatory and Legal Activities, January 2018-May 2023
Figure 46: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
Figure 47: Mergers and Acquisitions, January 2018-May 2023
Figure 48: New Offerings, January 2018-May 2023
Figure 49: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
Figure 50: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
Figure 51: Bayer AG: Product Portfolio
Figure 52: Bayer AG: Overall Financials, $Million, 2020-2022
Figure 53: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
Figure 54: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
Figure 55: Bayer AG: R&D Expenditure, $Million, 2020-2022
Figure 56: Bracco Group: Product Portfolio
Figure 57: Fresenius SE & Co. KGaA: Product Portfolio
Figure 58: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
Figure 59: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
Figure 60: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
Figure 61: Guerbet: Product Portfolio
Figure 62: Guerbet: Overall Financials, $Million, 2020-2022
Figure 63: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
Figure 64: ulrich GmbH & Co. KG: Product Portfolio
LIST OF TABLES
Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
Table 2: Key Questions Answered in the Report
Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
Table 5: Some of the Contrast Media Reactions and Effects
Table 6: Guidelines for Contrast Administration and Hydration
Table 7: Europe Contrast Media Agent and Injector System Market, Impact Analysis
Table 8: Contrast Media Ecosystem Active Players
Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
Table 2: Key Questions Answered in the Report
Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
Table 5: Some of the Contrast Media Reactions and Effects
Table 6: Guidelines for Contrast Administration and Hydration
Table 7: Europe Contrast Media Agent and Injector System Market, Impact Analysis
Table 8: Contrast Media Ecosystem Active Players
